产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
产品简介
小鼠神经小胶质细胞完全培养基由普诺赛技术团队精心优化，经过长期测试，本产品可保持小鼠神经小胶质细胞最佳的生长状态。本产品中已包含小鼠神经小胶质细胞生长所需的各种成分，无需添加任何成分，可直接用于小鼠神经小胶质细胞的体外培养。本产品仅供进一步科研使用，不得用于诊断、治疗、临床、家庭及其它用途。
产品说明
| 产品形态 | 液体 |
| 产品浓度 | 1× |
| 产品规格 | 100mL/125mL×4 |
| 细菌检测 | 阴性 |
| 真菌检测 | 阴性 |
| 支原体检测 | 阴性 |
| 细胞生长实验 | 细胞生长良好，形态正常 |
| 内毒素含量(EU/mL) | ≤3 |
| 储存条件 | 2~8℃，避光储存 |
| 运输条件 | 冰袋冷藏运输 |
| 有效期 | 3个月 |
注意事项
1. 使用产品时应注意无菌操作，避免污染。 2. 本产品为全营养组分的培养基，如无特别需要不用额外再添加血清和双抗，可以直接使用。 3. 为保持本产品的最佳使用效果，不宜将其长时间放置于室温或较高的温度环境中。 4. 所有产品请于保质期内使用，超出保质期，必须放弃使用。 5. 本产品只供进一步科研使用，不可应用于临床等其他方面。
参考文献
-
Long non-coding RNA MIR17HG impedes FOSL2-mediated transcription activation of HIC1 to maintain a pro-inflammatory phenotype of microglia during intracerebral haemorrhage (2023-10-17)
作者：Yunzheng Ai: 1.Department of Neurosurgery, General Hospital of Northern Theater Command, Shenyang, China;2.Contribution: Conceptualization (equal), Data curation (equal), Formal analysis (equal), Investigation (equal), Methodology (equal), Validation (equal), Writing - original draft (equal), Writing - review & editing (equal); Ying Kong: 1.Department of Neurology, General Hospital of Northern Theater Command, Shenyang, China;2.Contribution: Conceptualization (equal), Data curation (equal), Formal analysis (equal), Methodology (equal), Validation (equal), Writing - original draft (equal), Writing - review & editing (equal); Zheng Zou: 1.Department of Neurosurgery, General Hospital of Northern Theater Command, Shenyang, China;2.Contribution: Conceptualization (equal), Formal analysis (equal), Methodology (equal), Project administration (equal), Validation (equal), Visualization (equal), Writing - review & editing (equal); Ligang Chen: 1.Department of Neurosurgery, General Hospital of N
期刊：Long non-coding RNA MIR17HG impedes FOSL2-mediated transcription activation of HIC1 to maintain a pro-inflammatory phenotype of microglia during intracerebral haemorrhage
影响因子 ：3.4
引用产品： 小鼠脑动脉血管内皮细胞 , 小鼠神经小胶质细胞完全培养基
-
Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer’s disease (2022-08-03)
作者：Xiao-Gang Zhou:1.Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Key Laboratory of Medical Electrophysiology of Ministry of Education, School of Pharmacy, Southwest Medical University, Luzhou, 646000, China. ; Wen-Qiao Qiu:1.Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation for Chinese Materia Medica, Key Laboratory of Medical Electrophysiology of Ministry of Education, School of Pharmacy, Southwest Medical University, Luzhou, 646000, China. ; 2.Department of Neurosurgery Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, 610000, China. ; Lu Yu:1.Sichuan Key Medical Laboratory of New Drug Discovery and Drugability Evaluation, Luzhou Key Laboratory of Activity Screening and Druggability Evaluation fo
期刊：Targeting microglial autophagic degradation of the NLRP3 inflammasome for identification of thonningianin A in Alzheimer’s disease
DOI：10.1186/s41232-022-00209-7
影响因子 ：10.4
引用产品： 小鼠神经小胶质细胞 , 小鼠海马神经元细胞 , 小鼠神经小胶质细胞完全培养基 , 小鼠海马神经元细胞完全培养基
FAQs
Q：{{item.question}}
A：
产品资料
识别码示意图
